Clinical trial
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects…
NCT00307489 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00307489 |
|---|---|
| Title | Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil |
| Official title | A Phase 2, Randomized, Double-Blind Study Exploring the Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate (DF) Monotherapy Versus Emtricitabine Plus Tenofovir DF Fixed-Dose Combination Therapy in Subjects Currently Being Treated With Adefovir Dipivoxil for Chronic Hepatitis B and… |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | tenofovir DF, emtricitabine /tenofovir DF |
| Enrollment | 106 |
| Start date | Mar 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Oct 1, 2010 |
| First posted | Mar 28, 2006 |
| Last update posted | Nov 1, 2011 |
| Countries | France, Germany, Spain, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: